GVR Report cover Sample Preparation Market (2026 - 2033)Report

Sample Preparation Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product (Instruments, Consumable, Kits), By Technique (Protein Preparation, Solid-phase Extraction), By Application (Genomics, Proteomics, Epigenomics), By End Use, By Region, And Segment Forecasts

Market Size, 2025

$8.4B

Market Estimate, 2026

$8.9B

Market Forecast, 2033

$13.3B

CAGR, 2026–2033

5.9%

Sample Preparation Market Summary

The global sample preparation market size was valued at USD 8.4 billion in 2025 and is projected to grow from USD 8.9 billion in 2026 to USD 13.3 billion by 2033, at a CAGR of 5.9% from 2026 to 2033. North America dominated the global market with the largest revenue share of 41.1% in 2025. Sample preparation is the first step in any analytical process. 

Sample preparation market overview: Grand View Research estimates the global market size at USD 8.4 billion in 2025, projected to grow from USD 8.9 billion in 2026 to USD 13.3 billion by 2033 at a 5.9% CAGR, with regional growth momentum.

Key Market Trends & Insights

  • By product: Consumables segment held the largest revenue share of over 62.2% in 2025.
  • By technique: Protein preparation segment held the largest revenue share of over 45.3% in 2025.
  • By application: Genomics segment held the largest revenue share of over 31.0% in 2025.
  • By end-use: Diagnostic center segment held the largest revenue share of over 40.6% in 2025.

Regional Highlights

  • Largest regional market: North America (41.1% revenue share, 2025)
  • Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
  • By country: The sample preparation market in the U.S. held the largest share in the North America region in 2025.

Market Size & Forecast

  • Market Size in 2025: USD 8.4 Billion
  • Estimated Market Size in 2026: USD 8.9 Billion
  • Projected Market Size by 2033: USD 13.3 Billion
  • CAGR (2026-2033): 5.9%


The increasing advancement of technology in the collection and preparation of specimen is anticipated to be the key determinant of growth in the market. For instance, in October 2022, Thorne HealthTech, Inc. collaborated with GenTegra to develop a next-generation collection and extraction kit for whole blood DNA. The partnership will allow companies to develop a new product by integrating GenTegra patented technology of active chemical protection with Thorne’s collection device. This strategy is to the used comparative advantage of both companies to generate high revenue at low costs of R&D.

The market has witnessed a substantial increase in revenue due to the COVID-19 pandemic. Increasing demand for sample preparation in various applications assisted startups in the fundraising process. For instance, in September 2022, two startups, Inso Biosciences, Inc. and Halomine, Inc. announced to receive grants for developing and commercializing solutions for COVID-19 research. The aggregate amount for 18 grants by the New York State Biodefense Commercialization Fund was USD 15.3 million. While Inso Biosciences, a platform developer for genomic sample preparation received USD 955,000.

Sample Preparation market size and growth forecast (2023-2033)

Similarly, companies are taking the initiative to enhance and maintain the integrity of the specimen for accurate results. For instance, in September 2022, an Australian-based bioanalytical lab, Agilex Biolabs established its first satellite processing lab to support the clinical trials. The lab is expected to conduct time-sensitive sample processing approaches in the same location as clinical trial participants. Hence, this stores the integrity that might decline during the transportation of the specimen. The lab also has expertise in numerous sample preparation techniques, such as whole blood stimulation for cytokine release assays.

Expanding the scope of sample preparation techniques in various types of sequencing is anticipated to drive the growth of the market. The techniques differ according to the type of sequencing being conducted, and the use of technology is considered for sample preparation. For instance, in target sequencing, the requirement of sample input is less as compared to other sequencing types. The key approaches are amplicon sequencing and hybridization capture. The volume of sequencing data is growing, hence driving the requirement for further diverse protocols for sample preparation.

Moreover, in October 2022, 10x Genomics collaborated with Oxford Nanopore Technologies to build a comprehensive sequencing solution for full-length isoform single-cell and spatial sequencing. The collaboration is to allow a streamlined sequencing workflow with integrated sample preparation on highly accessible devices. Hence, the solution is anticipated to improve the result's resolution and process high-yield whole genome sequencing data in hours rather than days.

However, the installation and maintenance of equipment for sample preparation are complex. Along with that, the technology for sample preparation differs depending on the applications, adding further cost and time for the users.

Market Dynamics

The sample preparation market is witnessing significant growth, driven by increasing demand for efficient and reliable sample processing across genomics, proteomics, molecular diagnostics, and biopharmaceutical research. The rising adoption of advanced analytical technologies such as next-generation sequencing (NGS), PCR, mass spectrometry, and chromatography, coupled with growing investments in life sciences research and precision medicine, is fueling market expansion. In addition, advancements in automated, high-throughput sample preparation systems, increased biomarker discovery activities, and expanding applications in clinical diagnostics, environmental testing, and food safety are expected to further support market growth over the forecast period.

Technological advancements in sample preparation technologies are a key driver of market growth, as laboratories increasingly seek solutions that improve workflow efficiency, reproducibility, and analytical accuracy. Innovations such as automated sample preparation systems, robotic liquid handling platforms, microfluidics-based technologies, and integrated extraction and purification workflows are reducing manual intervention and minimizing processing errors. These advancements are particularly important in genomics, proteomics, clinical diagnostics, and pharmaceutical research, where high-throughput processing and consistent sample quality are critical for reliable results.

The industry continues to witness significant innovation focused on laboratory automation and workflow optimization. For instance, in April 2025, QIAGEN announced plans to launch three new sample preparation instruments, QIAsymphony Connect, QIAsprint Connect, and QIAmini, designed to enhance laboratory automation and improve operational efficiency across different throughput requirements. Such developments highlight the growing emphasis on advanced, automated sample preparation solutions and are expected to support market expansion over the forecast period.

Data privacy and genomic data management concerns represent a significant challenge for the sample preparation market. Sequencing technologies generate large volumes of sensitive genetic information that must be securely stored, processed, and shared across research institutions, healthcare providers, and biopharmaceutical companies. Concerns regarding unauthorized access, data breaches, and misuse of personal genomic information can limit participation in genomic studies and slow the adoption of sequencing-based diagnostics and precision medicine initiatives.

In addition, evolving data protection regulations and compliance requirements increase operational complexity for organizations utilizing sequencing technologies. Laboratories and healthcare institutions must invest in secure data infrastructure, governance frameworks, and cybersecurity measures to ensure regulatory compliance and maintain patient confidentiality. These challenges can increase the overall cost and complexity of sequencing programs, potentially restraining the broader adoption of sequencing technologies and associated reagents, particularly in clinical settings.

The increasing shift toward decentralized clinical research and patient-centric healthcare presents a significant opportunity for the sample preparation market. Traditional blood collection methods rely on venipuncture, clinical visits, and cold-chain logistics, which can increase costs, limit participant recruitment, and introduce pre-analytical variability. As clinical research organizations, biopharma companies, and genomics laboratories seek more accessible and scalable testing approaches, demand is rising for solutions that enable remote blood collection, sample stabilization, ambient transport, and efficient downstream molecular analysis.

For instance, in April 2026, Covaris launched the truCOLLECT Solution, an integrated platform for decentralized whole blood collection and DNA extraction. The solution enables fingerstick-based blood collection with on-device stabilization, ambient storage, and shipping without cold-chain requirements, and direct extraction of assay-ready DNA suitable for next-generation sequencing (NGS). When combined with Covaris' truCOVER Library Preparation kits, the platform provides an end-to-end workflow from at-home sample collection to sequencing-ready DNA. These advancements are expected to accelerate the adoption of decentralized genomic testing and sustain demand for sample preparation technologies across clinical research and biopharma applications.

 

Analyst Perspective

The sample preparation market is expected to witness sustained growth, driven by the increasing demand for accurate and efficient sample processing across genomics, proteomics, diagnostics, and biopharmaceutical research. Rising adoption of next-generation sequencing (NGS), growing clinical testing volumes, and advancements in laboratory automation are accelerating the need for high-quality sample preparation workflows. Continuous innovation in extraction, purification, and liquid handling technologies is enhancing workflow efficiency and reproducibility, while expanding investments in precision medicine and life science research are expected to support long-term market growth.

Product Insights

Based on product, the consumables segment held the largest revenue share of over 62.2% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. The consumables are primarily recurring in nature and are less susceptible to the seasonality of the market and industry cycles as compared to instruments. For instance, in May 2022, PacBio announced a 22.16% increase in the consumables revenue from USD 10.4 million in the previous year to USD 12.7 million having a positive impact on segment growth.

The instruments segment is considered to have a stable growth rate during the forecasted period. The purchase frequency of instruments by the End-uses is low owing to a higher lifespan and pricing than consumables. For End-uses, it is essential to incorporate accurate quality instruments to eliminate potential interfering contamination from the sample. For instance, the nucleic acid extraction sample preparation system by Bioteke Corporation is an automated instrument for the extraction process of DNA/RNA.

The increasing innovation in product offerings by the players is anticipated to support the market share of instruments during the forecast period. For instance, in October 2022, Thermo Fisher Scientific launched a comprehensive and automated system for sample preparation of chromatography. It is considered to be the first of its kind to extract and concentrate components from semi-solid and solid samples in a single instrument. The product eliminates the need for manual transferring from a walk-away sample to a vial workflow.

Technique Insights

Based on technique, the protein preparation segment held the largest revenue share of over 45.3% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. The increasing innovation in proteomics is likely to surge the overall market. The extraction process from the sample can result in the loss of proteins by eliminating contaminants and lowering the data reproducibility. In July 2022, researchers from the Babraham Institute advanced the conventional protocols of sample preparation in proteomics by developing a new approach. The technique increases the inclusion of hard to capture cellular proteins, hence improving the readouts of proteomics.

The solid-phase extraction segment accounted for a considerable revenue share in 2021. The expansion of techniques in various fields, such as food and environment, is likely to impact the overall market growth. For instance, in October 2022, Waters Corporation announced to launch Extraction+ connected device that can perform automation preparation of forensics, biological, environmental, and food specimens via solid phase extraction. The solution eliminates the requirement for a manual pipette and extraction of the sample.

Similarly, the development of supplementary products to perform liquid-liquid extraction techniques is considered to be a supporting factor for market growth. For instance, in October 2022, nRichDX introduced two products for use with a sample preparation system. This strategic initiative assisted the company in enhancing its applications in liquid biopsy.

Application Insights

Based on application, the genomics segment held the largest revenue share of over 31.0% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. Increasing strategic initiatives by companies in the market for genomics applications are expected to surge the overall growth rate. For instance, in October 2022, Bionano Genomics, Inc. and Hamilton announced the joint development of a product to extract and isolate Ultra High Molecular Weight DNA as the initial part of the sample preparation workflow. The use of long string vantage is in optical genome mapping.

One of the key drivers of this application is expanding the technique for developing personalized treatment through genomics research. For instance, in October 2022, Sight Diagnostics, a technology developer in blood sample preparation, installed its first portable instrument for hematology analysis in the Caribbean. The instrument is installed to offer immediate complete blood count to Tobago and Trinidad patients and assist in diagnosing patients with oncology, critically ill, and pediatrics.

Similarly, numerous approaches such as extraction and separation, are developing aligned with smart devices, lab automation, and biosensors. Technological advancement in the market is anticipated to ease the adoption rate by the end users. For instance, in April 2020, an article published on a portal by Cambridge Healthtech Institute stated that sample preparation has substantial potential in a point-of-care setting. The article underlined developing sample-preparing techniques such as electrokinetic-like separation and electrowetting, which can be incorporated in a PoC setting.

End Use Insights

Based on end use, the diagnostic center segment held the largest revenue share of over 40.6% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. The segment in the sample preparation market is estimated to be skewed toward the mature regions, majorly in Western Europe, North America, and Japan. However, increasing spending on human health in emerging markets is likely to drive the market.

Sample Preparation Market Share

The sample preparation has become an integrated part of the multiple areas’ value chain, including therapeutic research, discovery and development, clinical trials, manufacturing and quality assurance, and quality control. Hence, advancement in collection methods is expected to ease the preparation process for the End-uses. For instance, in October 2022, Tasso collaborated with Catapult Health to commercialize its U.S. FDA-cleared device for collecting blood specimens at home. Hence, pharmaceutical and biotechnology companies also showcased stable growth in the market.

Regional Insights

North America dominated the sample preparation market with the largest revenue share of 41.1% in 2025. The important parament of the largest market share is the presence of well-established suppliers and buyers of the sample preparation solutions in the region. Hence, this speeds up the delivery process from supplier to buyer at a minimal cost. Additionally, increasing accessibility and availability of funds through government and private investors support startup companies to enter the market. 

Sample Preparation Market Trends, by Region, 2026 - 2033

U.S. Sample Preparation Market Trends

The sample preparation market in the U.S. held the largest share in the North America region in 2025. The sample preparation market in the U.S. is primarily driven by advancements in biopharmaceutical research, drug discovery, and clinical diagnostics. The rising demand for personalized medicine, genomics, and proteomics research has fueled the adoption of automated and high-throughput sample preparation systems. Moreover, government initiatives supporting biotechnology and pharmaceutical industries play a pivotal role, coupled with increasing R&D spending in the healthcare sector.

Europe Sample Preparation Market Trends

The sample preparation market in Europe is supported by strong research institutions and pharmaceutical companies. Countries like Germany, France, and the UK are prominent players, benefiting from government-funded research projects and the growing focus on personalized healthcare solutions. Additionally, the rising focus on environmental testing and food safety regulations has further bolstered the demand for advanced sample preparation technologies.

The UK sample preparation market benefits from a robust pharmaceutical and biotechnology sector, driving the need for efficient sample preparation methods. The increasing use of advanced technologies in molecular diagnostics and genomics research, coupled with substantial government funding and collaborative projects between academic institutions and industry players, propels the market growth.

The sample preparation market in France is supported by government initiatives to support research and development in the life sciences sector. The country’s focus on genomic research and the growing importance of personalized medicine contribute to the demand for innovative sample preparation techniques. Additionally, collaborations between pharmaceutical companies and academic institutions boost technological advancements in this market​.

Germany sample preparation market is driven by its well-established biotechnology and pharmaceutical industries which has a high demand for automated sample preparation systems in proteomics, genomics, and drug discovery. The country's focus on precision medicine, coupled with its strong R&D infrastructure and government support for healthcare innovation, is a significant market driver.

Asia Pacific Sample Preparation Market Trends

The sample preparation market in Asia Pacific is projected to experience the fastest CAGR in the market. This can be attributed to the increasing adoption of sequencing in China and India for numerous applications, including the development of personalized medicines. Furthermore, the increasing attention to genomics and proteomics research in the Asia Pacific region is anticipated to impact the market with significant growth opportunities during the forecast period.

China sample preparation market is expanding rapidly due to increasing investments in biotechnology, healthcare, and pharmaceutical research. The country’s focus on improving healthcare infrastructure, along with rising demand for molecular diagnostics and genomics, drives the adoption of advanced sample preparation technologies. Government support and growing interest in drug discovery and development further fuel market growth. 

The sample preparation market in Japan is driven by advancements in genomics, proteomics, and personalized medicine. The country’s strong focus on healthcare innovations, combined with significant investment in R&D by pharmaceutical and biotech companies, boosts demand for high-throughput and automated sample preparation systems. Additionally, Japan’s aging population increases the need for advanced diagnostic solutions, which enhances the market. 

India sample preparation market is driven by its growing pharmaceutical and biotechnology industries, alongside increasing investments in healthcare R&D. The rising prevalence of chronic diseases and the growing focus on molecular diagnostics and drug discovery boost the demand for efficient sample preparation techniques. Additionally, government initiatives to improve healthcare infrastructure and boost biopharmaceutical production further support market growth. 

Middle East & Africa Sample Preparation Market Trends

The sample preparation market in the Middle East & Africa is driven by increasing investments in healthcare infrastructure and rising demand for advanced diagnostic tools. The region is focusing on improving clinical research capabilities, with countries like South Africa and UAE playing a crucial role in market growth. The need for efficient sample preparation in diagnostic labs and research centers is rising due to growing disease prevalence. 

Saudi Arabia sample preparation market is driven by significant investments in healthcare and clinical research, as the country focuses on developing its biotechnology and pharmaceutical sectors. The growing demand for molecular diagnostics, coupled with the government’s Vision 2030 initiative to modernize healthcare, boosts the need for advanced sample preparation techniques​. 

The sample preparation market in Kuwait is driven by increasing healthcare investments and a growing focus on improving diagnostic capabilities. The rising prevalence of chronic diseases, coupled with the country’s efforts to upgrade its healthcare infrastructure, creates a demand for efficient and automated sample preparation technologies in diagnostic and research laboratories.

Key Sample Preparation Company Insights

Companies in the sample preparation market are constantly indulging in numerous strategies such as technology development, innovation in the product line, collaborations, building a strong market presence through mergers and acquisitions, startups, and expanding regional footprint, to generate higher revenue.

Key Sample Preparation Companies

The following key companies have been profiled for this study on the sample preparation market.

  • Merck KGaA

  • Thermo Fisher Scientific Inc.

  • Bio-RAD Laboratories Inc.

  • Tecan Group Ltd.

  • Agilent Technologies Inc.

  • Hamilton Company

  • Promega Corporation

  • Illumina Inc.

  • Danaher

  • Qiagen N.V.

Competitive Benchmarking

Category

Operating Strategies

Competitive Edge

Weakness

Established Players (Merck KGaA, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, etc.)

  • Focus on providing integrated sample preparation workflows by combining instruments, consumables, automation platforms, and downstream analytical solutions.
  • Strong global presence, broad product portfolios, and extensive customer networks across pharmaceutical, biotechnology, clinical, and academic research sectors.
  • High dependence on research funding, pharmaceutical R&D spending, and capital-intensive laboratory investments.

Emerging Players (Bio-Rad Laboratories, Tecan Group, Hamilton Company, etc.)

  • Focus on specialized sample preparation technologies, laboratory automation, and application-specific solutions for research and diagnostics.
  • Strong expertise in niche applications, flexible product customization, and innovative automation technologies.
  • Limited scale and narrower product portfolios compared to diversified life science market leaders.

Recent Developments

  • In November 2023, QIAGEN expanded its sample technology offerings with the launch of two new solutions designed to assist researchers in processing a range of materials such as bone, tissue, and soil samples. The newly introduced products, TissueLyser III and the RNeasy PowerMax Soil Pro Kit, reflect QIAGEN's dedication to advancing its automated sample preparation tools. TissueLyser III, in particular, underscores the company’s commitment to continuously enhancing efficiency and innovation in sample preparation and analysis workflows.

  • In September 2023, DPX Technologies, a producer of laboratory consumables for sample preparation, announced its business expansion. This growth includes the introduction of new product lines focused on proteomics and genomics testing, as well as the construction of a larger storage facility to support its increased capacity and future product development efforts.

  • In October 2022, Thermo Fisher Scientific announced it to expand its clinical research lab in Kentucky by investing USD 59 million. The expansion is to support customers for their clinical testing requirements, including sample management, processing, storage, and preparation. 

Sample Preparation Market Report Scope

Report Attribute

Details

Market size in 2025

USD 8.4 billion

Estimated market size in 2026

USD 8.9 billion

Projected market size by 2033

USD 13.3 billion

Growth rate

CAGR of 5.9% from 2026 to 2033

Historical data

2021 - 2025

Forecast period

2026 - 2033

Quantitative units

Revenue in USD million and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, technique, application, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Norway, Denmark, Sweden, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, Saudi Arabia, South Africa, UAE, Kuwait

Key companies profiled

Merck KGaA, Thermo Fisher Scientific Inc., Bio-RAD Laboratories Inc., Tecan Group Ltd., Agilent Technologies Inc., Hamilton Company, Promega Corporation, Illumina Inc., Danaher Corporation, Qiagen N.V.

Customization scope

Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Sample Preparation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sample preparation market report on the basis of product, technique, application, end-use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

    • Instruments

      • Extraction System

      • Workstation

      • Automated Evaporation System

      • Liquid Handling Instrument

        • Liquid handling workstations

        • Pipetting systems

        • Reagents dispensers

        • Microplate washer

        • Other liquid handling systems

    • Consumable

    • Kits

      • Purification Kit

      • Isolation Kit

      • Extraction Kit

  • Technique Outlook (Revenue, USD Million, 2021 - 2033)

    • Protein Preparation

    • Solid-phase extraction

    • Liquid-liquid extraction

  • Application Outlook (Revenue, USD Million, 2021 - 2033)

    • Genomics

    • Proteomics

    • Epigenomics

    • Transcriptomics

    • Metabolomics

    • Others

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals

    • Diagnostic Centers

    • Pharmaceutical and Biotechnology Industry

    • Others

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Research Methodology

Segment Definition

Segment- Product

Revenue Capture Definition

Instruments

Revenue is generated from equipment that automates, streamlines, and standardizes sample preparation workflows across genomics, proteomics, diagnostics, and life science research applications. This segment includes extraction systems for nucleic acid and protein isolation, workstations for integrated sample processing, automated evaporation systems for sample concentration, and liquid-handling instruments such as liquid-handling workstations, pipetting systems, reagent dispensers, microplate washers, and other automated liquid-processing platforms that enhance laboratory efficiency and reproducibility.

Consumables

This segment captures income from single-use products routinely consumed during sample preparation procedures. These consumables support sample collection, processing, purification, storage, and workflow optimization while ensuring consistency and minimizing contamination risks across research and clinical laboratory settings.

Kits

Market value in this category stems from ready-to-use sample preparation kits designed to simplify extraction, purification, and isolation processes. The segment includes purification kits for removing contaminants from biological samples, isolation kits for separating target biomolecules such as DNA, RNA, proteins, and cells, and extraction kits for recovering nucleic acids, proteins, and other analytes for downstream analytical applications.

Segment- Technique

Revenue Capture Definition

Protein Preparation

Revenue originates from products and solutions used in protein extraction, purification, enrichment, fractionation, and sample processing workflows. These techniques support protein characterization, biomarker discovery, proteomics studies, therapeutic development, and other protein-based research applications.

Solid-Phase Extraction

This segment reflects earnings from sample preparation technologies that utilize solid sorbent materials to isolate, purify, and concentrate target compounds from complex biological, pharmaceutical, environmental, and clinical samples prior to analysis.

Liquid-Liquid Extraction

Demand within this category is driven by sample preparation methods that separate analytes based on differential solubility between immiscible liquid phases. These techniques are widely applied in pharmaceutical testing, toxicology, clinical diagnostics, and analytical chemistry workflows.

Segment- Application

Revenue Capture Definition

Genomics

Revenue is generated from sample preparation products used in DNA and RNA extraction, purification, enrichment, and processing workflows supporting sequencing, genetic testing, biomarker discovery, and molecular biology research.

Proteomics

This segment captures income from sample preparation solutions utilized in protein isolation, purification, digestion, and characterization studies aimed at understanding protein structure, function, and interactions.

Epigenomics

Market value arises from sample preparation workflows designed for the analysis of epigenetic modifications such as DNA methylation, histone modifications, and chromatin accessibility associated with gene regulation studies.

Transcriptomics

Revenue stems from products used in RNA isolation, enrichment, purification, and preparation processes supporting gene expression analysis, RNA sequencing, and transcript profiling applications.

Metabolomics

This category reflects earnings from sample preparation technologies employed for the extraction, purification, and analysis of metabolites in biological systems to support metabolic pathway and disease research.

Others

Includes revenue from sample preparation applications in microbiomics, cell biology, forensic science, environmental testing, toxicology, and other emerging life science disciplines.

Segment- End Use

Revenue Capture Definition

Hospitals

Revenue originates from sample preparation products used in hospital laboratories for disease diagnosis, molecular testing, pathology analysis, infectious disease screening, and patient monitoring applications.

Diagnostic Centers

This segment represents income generated from sample preparation solutions utilized in independent diagnostic laboratories and testing centers conducting routine clinical, molecular, and genetic analyses.

Pharmaceutical and Biotechnology Industry

Demand in this category is driven by the use of sample preparation technologies in drug discovery, biomarker research, biologics development, clinical trials, quality control, and biopharmaceutical manufacturing.

Others

Includes revenue from academic research institutes, contract research organizations (CROs), forensic laboratories, government agencies, environmental testing facilities, and other organizations engaged in analytical and life science research.

Delivered Customizations

This report has been delivered with the following In-depth customizations

Client Request

Customization Delivered

Value Adds

Product & Technology Cross-Segmentation Analysis for Sample Preparation Market

Detailed breakdown of the market across key product categories including instruments (extraction systems, liquid handling platforms, workstations), consumables (kits, reagents, columns, plates), and accessories/software, along with segmentation by techniques such as solid-phase extraction, liquid-liquid extraction, protein precipitation, filtration, and centrifugation.

Enables identification of high-growth product-technology combinations, supports portfolio prioritization across consumables vs instruments, and highlights adoption trends in automated and high-throughput sample preparation workflows across life science applications.

Application & End-Use Demand Assessment Across Life Sciences Workflows

Customized analysis of demand across major applications, including genomics, proteomics, transcriptomics, epigenomics, metabolomics, and analytical chemistry workflows (HPLC, LC-MS, GC-MS), mapped with end-use industries such as pharmaceutical & biotechnology companies, diagnostic laboratories, hospitals, and academic & research institutes.

Helps clients understand workflow-driven demand hotspots, identify high-volume application areas such as genomics and proteomics, and prioritize commercialization strategies across the pharma, diagnostics, and research ecosystems.

Regional & Competitive Intelligence Benchmarking

Country and regional-level assessment across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, combined with benchmarking of key players based on automation capabilities, reagent portfolio strength, instrument innovation, and strategic collaborations in sample preparation workflows.

Supports strategic expansion planning, identification of emerging regional markets (especially APAC biotech hubs), competitive positioning, and evaluation of innovation-driven differentiation opportunities in automated sample preparation solutions.

Frequently Asked Questions About This Report

About the Author(s)

Biotechnology Research Team

Healthcare · Biotechnology

This report was authored by the biotechnology research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the biotechnology segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo